Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Peanut Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering.
The Peanut Allergy Treatment Market was valued at USD 0.59 Billion in 2024, and is expected to reach USD 1.21 Billion by 2030, rising at a CAGR of 12.84%
The rising awareness about peanut allergies, coupled with technological advancements, is driving significant growth in this market. Peanut allergy is a life-threatening condition that continues to affect millions globally, prompting a surge in demand for effective treatment options.
Improved scientific understanding of allergy mechanisms has enabled the development of targeted therapies such as allergen-specific immunotherapy and gene-based treatments. The market has garnered attention from pharmaceutical companies and research organizations that are investing extensively in R&D to capitalize on the growing need for innovative and life-saving treatment solutions.
Rising Prevalence of Peanut Allergies
The global rise in peanut allergy cases is a major factor accelerating growth in the peanut allergy treatment market. In Western countries, incidence rates have risen sharply over the last two decades. For example, the prevalence among U.S. children grew from 0.4% in 1997 to 1.4% by 2008, while the UK saw childhood food allergies triple from 1.2% to 4% between 2008 and 2018.
This increase has intensified the demand for effective therapeutic solutions. Health authorities such as the CDC have flagged food allergies as a mounting public health concern, advocating for improved diagnostic and treatment frameworks. Parental concern and awareness regarding severe allergic reactions have spurred a push for more advanced interventions. As a result, pharmaceutical companies are intensifying efforts to develop treatments like biologics and immunotherapies to address this critical health issue, further propelling market expansion.
High Cost of Treatment
The high cost associated with peanut allergy therapies remains a major challenge for market penetration and equitable access. Treatments such as immunotherapy and biologics involve high expenses related to drug formulation, administration, monitoring, and managing side effects. These costs may be prohibitive, especially in areas with limited insurance coverage or healthcare funding.
Coverage discrepancies in insurance plans exacerbate affordability issues, discouraging patients from pursuing potentially effective care. Public healthcare systems also face budgetary pressures due to the high treatment costs. Overcoming this barrier requires cooperation among pharmaceutical companies, insurers, and government bodies. Implementing measures such as value-based pricing, enhanced insurance reimbursement, and patient support programs is essential to broaden treatment accessibility.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $0.59 Billion |
| Forecasted Market Value (USD) by 2030 | $1.21 Billion |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | Global |
Report Scope
Key Market Players:
- Vedanta Biosciences, Inc.
- Alladapt Immunotherapeutics, Inc.
- Regeneron Pharmaceuticals Inc.
- Aravax Pty Ltd
- Teva Pharmaceutical Industries Limited
- Prota Therapeutics Pty Ltd.
- Aimmune Therapeutics, Inc. (Nestle)
- DBV Technologies SA
- Sanofi SA
- Mylan N.V.
Peanut Allergy Treatment Market, By Drug Class:
- Antihistamines
- Epinephrine
- Immunotherapies
- Others
Peanut Allergy Treatment Market, By Route of Administration:
- Oral
- Intravenous
- Others
Peanut Allergy Treatment Market, By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Peanut Allergy Treatment Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
For more information about this report visit https://www.researchandmarkets.com/r/id6h09
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
